Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABCL
Nasdaq
8731
https://www.abcellera.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbCellera Biologics Inc
AbCellera Biologics Insiders Added US$2.47m Of Stock To Their Holdings
- Nov 24th, 2023 2:03 pm
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
- Nov 16th, 2023 9:05 pm
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
- Nov 3rd, 2023 4:05 pm
AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript
- Nov 3rd, 2023 2:51 pm
Q3 2023 Abcellera Biologics Inc Earnings Call
- Nov 3rd, 2023 12:42 pm
Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress
- Nov 3rd, 2023 9:55 am
AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript
- Nov 3rd, 2023 9:30 am
AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million
- Nov 2nd, 2023 9:56 pm
AbCellera Reports Q3 2023 Business Results
- Nov 2nd, 2023 8:05 pm
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
- Nov 1st, 2023 8:05 pm
AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
- Oct 31st, 2023 8:05 pm
Earnings Preview: AbCellera Biologics Inc. (ABCL) Q3 Earnings Expected to Decline
- Oct 26th, 2023 2:02 pm
AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023
- Oct 11th, 2023 8:05 pm
25 Biggest Stocks with Negative Beta
- Sep 29th, 2023 4:43 pm
AbCellera Announces Two T-Cell Engager Presentations at SITC 2023
- Sep 27th, 2023 1:00 pm
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
- Sep 20th, 2023 9:02 pm
Insider Buying: Veronique Lecault Acquires 20,000 Shares of AbCellera Biologics Inc
- Sep 14th, 2023 11:03 pm
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
- Sep 13th, 2023 1:00 pm
11 Cheap Small-Cap Stocks to Buy Before the Next Breakout
- Sep 1st, 2023 2:12 am
10 Stocks That Could 10X Over the Next 10 Years
- Aug 31st, 2023 11:37 am
Scroll